Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey

BACKGROUND: The Risk Evaluation and Mitigation Strategy (REMS) for retigabine/ezogabine (RTG/EZG) required an evaluation of the effectiveness of the communication plan to communicate about the risks with use of RTG/EZG. OBJECTIVE: GlaxoSmithKline conducted a survey to assess understanding of the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishihara, Lianna, Beck, Melissa, Travis, Sara, Akintayo, Olusegun, Brickel, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674522/
https://www.ncbi.nlm.nih.gov/pubmed/26690543
http://dx.doi.org/10.1007/s40801-015-0042-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674522/
https://www.ncbi.nlm.nih.gov/pubmed/26690543
http://dx.doi.org/10.1007/s40801-015-0042-5

Ejemplares similares